The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Adverum Biotechnologies Inc shares valued at $1,260,000 were sold by Leonard Braden Michael on Dec 01 ’25. At $4.20 per share, Leonard Braden Michael sold 300,000 shares. The insider’s holdings dropped to 2,757,526 shares worth approximately $11.5 million following the completion of this transaction.
Also, Leonard Braden Michael sold 222,925 shares, netting a total of over 929,597 in proceeds. Following the sale of shares at $4.17 each, the insider now holds 2,428,640 shares.
Before that, Leonard Braden Michael had sold 51,961 shares from its account. In a trade valued at $218,236, the 10% Owner traded Adverum Biotechnologies Inc shares for $4.20 each. Upon closing the transaction, the insider’s holdings decreased to 51,961 shares, worth approximately $11.28 million.
As published in a research note from H.C. Wainwright on November 17, 2025, Adverum Biotechnologies Inc [ADVM] has been rated down from a Buy to a Neutral. Analysts at Oppenheimer started covering the stock with ‘”an Outperform”‘ outlook in a report released in late June. As of April 30, 2024, H.C. Wainwright has initiated its “Buy” rating for ADVM. Earlier on July 07, 2022, Truist upgraded its rating. Their new recommendation was “a Buy” for ADVM stock which previously was a “a Hold”.
Analyzing ADVM Stock Performance
The stock’s lowest price that day was $4.17, but it reached a high of $4.24 in the same session. During the last five days, there has been a surge of approximately 0.24%. Over the course of the year, Adverum Biotechnologies Inc shares have dropped approximately -39.39%. Shares of the company reached a 52-week high of $5.75 on 10/02/25 and a 52-week low of $1.78 on 05/15/25.
Support And Resistance Levels for Adverum Biotechnologies Inc (ADVM)
According to the 24-hour chart, there is a support level at 4.14, which, if violated, would cause prices to drop to 4.12. In the upper region, resistance lies at 4.22. The next price resistance is at 4.27. RSI (Relative Strength Index) is 46.94 on the 14-day chart, showing neutral technical sentiment.
Is Adverum Biotechnologies Inc subject to short interest?
Stocks of Adverum Biotechnologies Inc saw a sharp steep in short interest on 2025-11-14 dropping by 63967.0 shares to 0.81 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 0.88 million shares. A decline of -7.88% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 0.93 of the overall float, the days-to-cover ratio (short ratio) decline to 0.93.
Which companies own the most shares of Adverum Biotechnologies Inc (ADVM)?
In terms of Adverum Biotechnologies Inc share price expectations, FactSet research, analysts set an average price target of 5 in the next 12 months, up nearly 19.9% from the previous closing price of $4.17. Analysts anticipate Adverum Biotechnologies Inc stock to reach 5.5 by 2025, with the lowest price target being 4. In spite of this, 2 analysts ranked Adverum Biotechnologies Inc stock as Buy at the end of 2025.
